These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 18074201)

  • 1. RNAi for treating hepatitis B viral infection.
    Chen Y; Cheng G; Mahato RI
    Pharm Res; 2008 Jan; 25(1):72-86. PubMed ID: 18074201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Countering hepatitis B virus infection using RNAi: how far are we from the clinic?
    Ivacik D; Ely A; Arbuthnot P
    Rev Med Virol; 2011 Nov; 21(6):383-96. PubMed ID: 21913277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs.
    Uprichard SL; Boyd B; Althage A; Chisari FV
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):773-8. PubMed ID: 15640346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains.
    Ren GL; Fang Y; Ma HH; Lei YF; Wang D; Xu MC; Wang PZ; Huang CX; Nie OH; Sun YT; Bai XF
    Antivir Ther; 2007; 12(6):865-76. PubMed ID: 17926641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
    Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
    Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNA drug development against hepatitis B virus infection.
    Flisiak R; Jaroszewicz J; Łucejko M
    Expert Opin Biol Ther; 2018 Jun; 18(6):609-617. PubMed ID: 29718723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells.
    Guo Y; Guo H; Zhang L; Xie H; Zhao X; Wang F; Li Z; Wang Y; Ma S; Tao J; Wang W; Zhou Y; Yang W; Cheng J
    J Virol; 2005 Nov; 79(22):14392-403. PubMed ID: 16254373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EsiRNAs inhibit Hepatitis B virus replication in mice model more efficiently than synthesized siRNAs.
    Xuan B; Qian Z; Hong J; Huang W
    Virus Res; 2006 Jun; 118(1-2):150-5. PubMed ID: 16423421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking sense-strand activity improves potency, safety and specificity of anti-hepatitis B virus short hairpin RNA.
    Michler T; Große S; Mockenhaupt S; Röder N; Stückler F; Knapp B; Ko C; Heikenwalder M; Protzer U; Grimm D
    EMBO Mol Med; 2016 Sep; 8(9):1082-98. PubMed ID: 27473329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in developing nucleic acid-based HBV therapy.
    Marimani M; Hean J; Bloom K; Ely A; Arbuthnot P
    Future Microbiol; 2013 Nov; 8(11):1489-504. PubMed ID: 24199806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of viral hepatitis B.
    Pramoolsinsup C
    J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of hepatitis B virus antigen production and replication by wild-type HBV dependently replicating HBV shRNA vectors in vitro and in vivo.
    Li B; Sun S; Li M; Cheng X; Li H; Kang F; Kang J; Dörnbrack K; Nassal M; Sun D
    Antiviral Res; 2016 Oct; 134():117-129. PubMed ID: 27591142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy for hepatitis B virus infections: new targets and technical challenges.
    Feld J; Locarnini S
    J Clin Virol; 2002 Dec; 25(3):267-83. PubMed ID: 12423691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice.
    Ebert G; Poeck H; Lucifora J; Baschuk N; Esser K; Esposito I; Hartmann G; Protzer U
    Gastroenterology; 2011 Aug; 141(2):696-706, 706.e1-3. PubMed ID: 21684282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
    Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
    Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for inhibiting the post-transcriptional regulation of gene expression in hepatitis B virus.
    Chen A; Panjaworayan T-Thienprasert N; Brown CM
    World J Gastroenterol; 2014 Jul; 20(25):7993-8004. PubMed ID: 25009369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug targets in hepatitis B virus infection.
    Stein LL; Loomba R
    Infect Disord Drug Targets; 2009 Apr; 9(2):105-16. PubMed ID: 19275699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
    Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting the RNA interference pathway to counter hepatitis B virus replication.
    Arbuthnot P; Carmona S; Ely A
    Liver Int; 2005 Feb; 25(1):9-15. PubMed ID: 15698393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.